Barclays Maintains Equal-Weight on Healthpeak Properties, Raises Price Target to $24
Barclays analyst Richard Hightower maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight and raises the price target from $23 to $24.
Stocks · News reference
RBC Capital Maintains Outperform on Healthpeak Properties, Raises Price Target to $24
RBC Capital analyst Michael Carroll maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields
In uncertain markets, investors turn to dividend-yielding stocks. Benzinga provides latest analyst ratings & news for high-yielding stocks.
Baird Maintains Outperform on Healthpeak Properties, Raises Price Target to $24
Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.
Citigroup Maintains Neutral on Healthpeak Properties, Raises Price Target to $22
Citigroup analyst Nick Joseph maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $20 to $22.